NFLX vs OBIO · P/E 25, rev $12.56B vs rev $198.0K
Netflix Inc (NFLX) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
NFLX currently screens at market cap $324.06B and trailing P/E 24.8. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the NFLX and OBIO stock pages for the full models.
Not investment advice.